Golden State Wealth Management »

Cue Biopharma shares owned by Golden State Wealth Management

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Golden State Wealth Management from 13F filings

Historical chart of Golden State Wealth Management investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Golden State Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Golden State Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $611 2.0k 0.31
2025-09-30 $1.4k 2.0k 0.72
2025-06-30 $1.4k 2.0k 0.68
2025-03-31 $1.8k 2.0k 0.91
2024-12-31 $2.2k 2.0k 1.09

More positions owned by Golden State Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
SPDR S&P MF Closed and MF Open (SPY)
Apple (AAPL)
Ishares Core MF Closed and MF Open (AGG)
NVIDIA Corporation (NVDA)
First Trust MF Closed and MF Open (FVD)
Invesco Qqq MF Closed and MF Open (QQQ)
Amazon (AMZN)
Alphabet Common Stock (GOOGL)
Harbor Etf Trust Long Term Grower (WINN)
American Century MF Closed and MF Open (QGRO)
Principal Us MF Closed and MF Open (USMC)
First Trust MF Closed and MF Open (RDVY)
Microsoft Corporation (MSFT)
State Street MF Closed and MF Open (SPAB)

View all positions for Golden State Wealth Management

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Group
Lion Point Capital
Geode Capital Management
Boothbay Fund Management
Robertson Stephens Wealth Management
BlackRock
Texas Capital Bank Wealth Management Services
Angeles Wealth Management
Advisory Research
Stifel Financial
Renaissance Technologies
State Street Corporation
Susquehanna International

View all funds holding Cue Biopharma